Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yuankang, Xie"'
Autor:
Binhui Xie, Baiyin Zhong, Zhenxian Zhao, Jie Hu, Jianqiong Yang, Yuankang Xie, Jianhong Zhang, Jianting Long, Xuewei Yang, Heping Li
Publikováno v:
Cancer & Metabolism, Vol 11, Iss 1, Pp 1-12 (2023)
Abstract Chemotherapy resistance is the leading cause for hepatocellular carcinoma (HCC)-induced death. Exploring resistance generation mechanism is an urgent need for HCC therapy. Here, we found STEAP4 was significantly downregulated in HCC patients
Externí odkaz:
https://doaj.org/article/84e7ae84c1034387ac442e633775ae0b
Autor:
Binhui Xie, Yuankang Xie, Cuifu Fang, Baiyin Zhong, Rong Ye, Jianhong Zhang, Qingquan Liu, Heping Li
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Previous studies have shown that Family with sequence similarity 134 member B (FAM134B) was involved in the occurrence and development of malignancy, however, the function and molecular mechanism of FAM134B in Hepatocellular Carci
Externí odkaz:
https://doaj.org/article/1b54f97365cf4367aa0f71deec20798c
Autor:
Baiyin Zhong, Zhonghui Xie, Jianhong Zhang, Xing Xie, Yuankang Xie, Binhui Xie, Jing Wang, Chuanbin Liu
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are major health burdens, with emerging evidence suggesting NAFLD as a significant risk factor for AF, but the mechanism is remain unclear.Methods: In this study, we a
Externí odkaz:
https://doaj.org/article/c448374e36974e2b97e6e29f6498a899
Autor:
Fengen Liu, Binhui Xie, Rong Ye, Yuankang Xie, Baiyin Zhong, Jinrong Zhu, Yao Tang, Zelong Lin, Huiru Tang, Ziqing Wu, Heping Li
Publikováno v:
Oncogenesis, Vol 12, Iss 1, Pp 1-12 (2023)
Abstract Triple-negative breast cancers (TNBC) frequently harbor defects in DNA double-strand break repair through homologous recombination (HR), such as BRCA1 dysfunction. However, less than 15% of TNBC patients were found to carry BRCA1 mutation, i
Externí odkaz:
https://doaj.org/article/1344558e420a4c54aa369f6e1a6768d4
Autor:
Binhui Xie, Yao Liu, Zhenxian Zhao, Qingquan Liu, Xiaonong Wang, Yuankang Xie, Yanhong Liu, Yuwen Liu, Yan Yang, Jianting Long, Qiangsheng Dai, Heping Li
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 58-69 (2020)
MYB proto-oncogene-like 1 (MYBL1) has been reported to be a strong activator of transcription and plays an important role in the development of cancer. However, the precise biological function and molecular mechanism of MYBL1 in hepatocellular carcin
Externí odkaz:
https://doaj.org/article/f7dfefea1caf44dba714e71527feb4c9
Publikováno v:
Corrosion Engineering, Science and Technology. 58:343-354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df02f71d27204dc01fc1d64d45543cff
https://doi.org/10.1080/1478422x.2023.2184521
https://doi.org/10.1080/1478422x.2023.2184521
Publikováno v:
BioMed Research International. 2023:1-9
Pancreatic cancer remains a deadly solid tumor with worst survival, and a better understanding of the mechanisms of carcinogenesis of pancreatic cancer is critical to promote the survival of patients with pancreatic cancer. qPCR and western blot assa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b77ba51165f227073220fdcb778b502
https://doi.org/10.1155/2023/7518744
https://doi.org/10.1155/2023/7518744
Publikováno v:
Drug Design, Development and Therapy. 17:15-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::954bc0f51a0466ff29ba8d1d1e0678cb
https://doi.org/10.2147/dddt.s385981
https://doi.org/10.2147/dddt.s385981
Autor:
Baiyin, Zhong, Caixin, Song, Qingfang, He, Zhixi, Chen, Qicheng, Liao, Qiusheng, Xiong, Shijie, Wang, Yuansheng, Xiao, Xing, Xie, Yuankang, Xie, Xiaonong, Wang, Jianhong, Zhang
Publikováno v:
Journal of Cancer. 13:975-986
Cholangiocarcinoma (CCA) is a type of cancer with a relatively low morbidity, but poor prognosis. Aberrant long non-coding RNA (lncRNA) expression has been observed in the pathological development of CCA. In the present study, lncRNA long intergenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4097f2fc93eb672c9fce0141f65f73
https://doi.org/10.7150/jca.66850
https://doi.org/10.7150/jca.66850
Autor:
Hongyu Meng, Ruixi Li, Yuankang Xie, Zhaohong Mo, Hang Zhai, Guangquan Zhang, Guohui Liang, Xianjie Shi, Boxuan Zhou
Publikováno v:
International Journal of Nanomedicine.
Hongyu Meng,1,2,* Ruixi Li,3,* Yuankang Xie,1,* Zhaohong Mo,2 Hang Zhai,2 Guangquan Zhang,3 Guohui Liang,4 Xianjie Shi,3 Boxuan Zhou1,2 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Gannan Medical University, Ganz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8198430ca3d92a413c887956e85c02b
https://www.dovepress.com/nanoparticles-mediated-circrobo1-silencing-to-inhibit-hepatocellular-c-peer-reviewed-fulltext-article-IJN
https://www.dovepress.com/nanoparticles-mediated-circrobo1-silencing-to-inhibit-hepatocellular-c-peer-reviewed-fulltext-article-IJN